Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
Journal of Parkinson'S Disease
|
April 17, 2026
Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein
Cassis Varlow, Anna Pees, Jeffrey S Stehouwer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 13, 2017
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
Patrick J Lao, Ben L Handen, Tobey J Betthauser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 17, 2015
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B
Patrick J Lao, Tobey J Betthauser, Ansel T Hillmer, et al.
RSC Medicinal Chemistry
|
April 21, 2025
The development of a PET radiotracer for imaging alpha synuclein aggregates in Parkinson's disease
Gui-Long Tian, Chia-Ju Hsieh, Dinahlee Saturnino Guarino, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 8, 2007
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees
William E Klunk, Julie C Price, Chester A Mathis, et al.
Neurobiology of Aging
|
November 26, 2013
Amyloid burden and neural function in people at risk for Alzheimer's Disease
Sterling C Johnson, Bradley T Christian, Ozioma C Okonkwo, et al.
Journal of Medicinal Chemistry
|
August 31, 2023
A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy
Ho Young Kim, Wai Kit Chia, Chia-Ju Hsieh, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 6, 2012
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease
Victor L Villemagne, William E Klunk, Chester A Mathis, et al.
Annals of Neurology
|
December 21, 2016
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies
Marta Marquié, Marc D Normandin, Avery C Meltzer, et al.
Molecular Neurodegeneration
|
February 25, 2025
<sup>18</sup>F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy
Michael L Alosco, Jhony Mejía Pérez, Julia E Culhane, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
Journal of Parkinson'S Disease
|
April 17, 2026
Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein
Cassis Varlow, Anna Pees, Jeffrey S Stehouwer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 13, 2017
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
Patrick J Lao, Ben L Handen, Tobey J Betthauser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 17, 2015
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B
Patrick J Lao, Tobey J Betthauser, Ansel T Hillmer, et al.
RSC Medicinal Chemistry
|
April 21, 2025
The development of a PET radiotracer for imaging alpha synuclein aggregates in Parkinson's disease
Gui-Long Tian, Chia-Ju Hsieh, Dinahlee Saturnino Guarino, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 8, 2007
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees
William E Klunk, Julie C Price, Chester A Mathis, et al.
Neurobiology of Aging
|
November 26, 2013
Amyloid burden and neural function in people at risk for Alzheimer's Disease
Sterling C Johnson, Bradley T Christian, Ozioma C Okonkwo, et al.
Journal of Medicinal Chemistry
|
August 31, 2023
A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy
Ho Young Kim, Wai Kit Chia, Chia-Ju Hsieh, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 6, 2012
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease
Victor L Villemagne, William E Klunk, Chester A Mathis, et al.
Annals of Neurology
|
December 21, 2016
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies
Marta Marquié, Marc D Normandin, Avery C Meltzer, et al.
Molecular Neurodegeneration
|
February 25, 2025
<sup>18</sup>F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy
Michael L Alosco, Jhony Mejía Pérez, Julia E Culhane, et al.
Page
of 21